Signal active
Bio
Ting Xu is the founder of Alphamab Co., focusing on the development of innovative protein/antibody engineering platform and biologics. Under his leadership, the company has developed a robust pipeline of about 30 biosimilars and 20 innovative biologics programs, several of which are in global clinical development. Prior to Alphamab, Dr. Xu worked in several US based biotechnology companies, including Serono and BiogenIdec, developing engineered proteins and downstream processes. Dr. Xu holds adjunct professor positions with Southeastern University. Dr. Xu holds a B.S. in Biochemistry from Nanjing University and a Ph.D. from the Chinese Academy of Science.
Location
N/A
Social
N/A
Primary Organization
2009
2
0
0
251-500
Biotechnology, Health Care, Pharmaceutical, Manufacturing, Therapeutics, Clinical Trials, Oncology
Jobs history
1
Alphamab Oncology
Board Chairman
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Xu Ting is the Founder & CEO at Alphamab Oncology. With a background in Biotechnology, Xu Ting has a rich history of leadership and innovation. Xu Ting studied B.S. Biochemistry @ Nanjing University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.